These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25132681)

  • 21. A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
    Semeraro M; Rizzo C; Boenzi S; Cappa M; Bertini E; Antonetti G; Dionisi-Vici C
    Clin Chim Acta; 2016 Jul; 458():159-64. PubMed ID: 27189059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of plasma fatty acids and risk of prostate cancer.
    Gann PH; Hennekens CH; Sacks FM; Grodstein F; Giovannucci EL; Stampfer MJ
    J Natl Cancer Inst; 1994 Feb; 86(4):281-6. PubMed ID: 8158682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human metabolism of phytanic acid and pristanic acid.
    Verhoeven NM; Jakobs C
    Prog Lipid Res; 2001 Nov; 40(6):453-66. PubMed ID: 11591435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ataxia associated with increased plasma concentrations of pristanic acid, phytanic acid and C27 bile acids but normal fibroblast branched-chain fatty acid oxidation.
    Clayton PT; Johnson AW; Mills KA; Lynes GW; Wilson J; Casteels M; Mannaerts G
    J Inherit Metab Dis; 1996; 19(6):761-8. PubMed ID: 8982949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phytanic acid alpha-oxidation in peroxisomal disorders: studies in cultured human fibroblasts.
    Verhoeven NM; Schor DS; Roe CR; Wanders RJ; Jakobs C
    Biochim Biophys Acta; 1997 Oct; 1361(3):281-6. PubMed ID: 9375802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AMACR polymorphisms, dietary intake of red meat and dairy and prostate cancer risk.
    Wright JL; Neuhouser ML; Lin DW; Kwon EM; Feng Z; Ostrander EA; Stanford JL
    Prostate; 2011 Apr; 71(5):498-506. PubMed ID: 20945498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the branched-chain fatty acids pristanic acid and Refsum disease-associated phytanic acid on mitochondrial functions and calcium regulation of hippocampal neurons, astrocytes, and oligodendrocytes.
    Rönicke S; Kruska N; Kahlert S; Reiser G
    Neurobiol Dis; 2009 Nov; 36(2):401-10. PubMed ID: 19703563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction.
    Poulos A; Sharp P; Fellenberg AJ; Johnson DW
    Eur J Pediatr; 1988 Feb; 147(2):143-7. PubMed ID: 2452737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phytanic acid and pristanic acid are oxidized by sequential peroxisomal and mitochondrial reactions in cultured fibroblasts.
    Verhoeven NM; Roe DS; Kok RM; Wanders RJ; Jakobs C; Roe CR
    J Lipid Res; 1998 Jan; 39(1):66-74. PubMed ID: 9469587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement of very long-chain fatty acids, phytanic and pristanic acid in plasma and cultured fibroblasts by gas chromatography.
    Dacremont G; Cocquyt G; Vincent G
    J Inherit Metab Dis; 1995; 18 Suppl 1():76-83. PubMed ID: 9053557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phytanic acid, pristanic acid, and very-long-chain fatty acid methyl esters measured simultaneously by capillary gas chromatography.
    Harris HM; Applegarth DA; Clarke LA; Wong J
    Clin Chem; 1989 Apr; 35(4):703-4. PubMed ID: 2702761
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on the degradation of [U-3H]-phytanic acid and [U-3H]-pristanic acid in cultured fibroblasts from children with peroxisomal disorders.
    Kase BF; Björkhem I
    Scand J Clin Lab Invest; 1996 May; 56(3):211-7. PubMed ID: 8761525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and dietary vitamin E in relation to prostate cancer risk.
    Weinstein SJ; Wright ME; Lawson KA; Snyder K; Männistö S; Taylor PR; Virtamo J; Albanes D
    Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1253-9. PubMed ID: 17548693
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer.
    Albanes D; Weinstein SJ; Wright ME; Männistö S; Limburg PJ; Snyder K; Virtamo J
    J Natl Cancer Inst; 2009 Sep; 101(18):1272-9. PubMed ID: 19700655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Zomer AW; van Der Burg B; Jansen GA; Wanders RJ; Poll-The BT; van Der Saag PT
    J Lipid Res; 2000 Nov; 41(11):1801-7. PubMed ID: 11060349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Family history of prostate cancer and prostate cancer risk in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study.
    Ahn J; Moslehi R; Weinstein SJ; Snyder K; Virtamo J; Albanes D
    Int J Cancer; 2008 Sep; 123(5):1154-9. PubMed ID: 18546266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of serum phospholipid fatty acids with breast cancer risk among postmenopausal cigarette smokers.
    Takata Y; King IB; Neuhouser ML; Schaffer S; Barnett M; Thornquist M; Peters U; Goodman GE
    Cancer Causes Control; 2009 May; 20(4):497-504. PubMed ID: 19255861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial.
    Goodman GE; Schaffer S; Omenn GS; Chen C; King I
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):518-26. PubMed ID: 12814997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.